Overview

Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of daptomycin against complicated skin and skin-structure infections in adults
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Daptomycin